期刊文献+

抗心律失常海洋新化合物C03的毒理学研究 被引量:2

Toxicological Researches of Anti-arrhythmic Ocean New Compound C03
下载PDF
导出
摘要 研究了C0 3(C0 3是从海星中分离并经结构修饰的新化合物 )对NIH小鼠的急性毒性作用及SD大鼠 90d长期毒性作用 ,实验结果表明 :新化合物C0 3测不出其LD50 ,最大耐受量每kg体质量 >1 5g ;对大鼠 90d连续灌胃给予样品 ,在 4 5d ,90d及 14d恢复期 ,分别对大鼠多项生化指标及其重要脏器 (心、肝、脾、肺、肾、子宫、卵巢、睾丸 )进行大体和组织病理学检查 ,在本实验剂量条件下 ,均未发现毒性反应或病理性改变 ,提示新化合物C0 3无毒副作用 ,服用安全。 A new compound C03 was separated and modified from from starfish nature produe.Acute toxic test and SD mouse 90_day_toxic test of C03 showed that the LD_ 50 of C03 can't be tested,and result of the most to lerance dose is more than 1 5 g/kg by test.In of giving C03,results of many biochemical indexes and important organs(including heart,liver,spleen,lung,kidney,womb,ovary and testicle)did not show toxic reactions or pathologic changes by dissection and microscopy examinations aftr giving simple C03 for 45,90 days and withdrawing 14 days.These showed that the new compound C03 had not toxic or side effect,was safe for giving.
出处 《中山大学学报(自然科学版)》 CAS CSCD 北大核心 2003年第4期51-54,共4页 Acta Scientiarum Naturalium Universitatis Sunyatseni
基金 国家 8 6 3计划资助项目 (2 0 0 1AA6 2 0 4 0 8 2 0 0 3AA6 2 0 4 0 80 )
关键词 海洋新化合物 急性毒性 长期毒理 ocean new compound acute acute test long_term toxcity
  • 相关文献

参考文献3

  • 1刘振龙 梅雪婷 许东晖 等.海星甾醇抗心律失常作用研究[J].中草药,2001,32:92-94.
  • 2许东晖,刘振龙,梅雪婷,许实波.海星甾醇抗实验性心律失常的作用[J].中国药科大学学报,2002,33(2):149-152. 被引量:17
  • 3SHUKLA R, Jowett N I, Thompson D R. Side effect with amiodarone therapy.Postgrad Med J,1994, 70(825): 492-498.

二级参考文献7

共引文献16

同被引文献21

  • 1周国华,于国萍.黑木耳多糖降血脂作用的研究[J].现代食品科技,2005,21(1):46-48. 被引量:96
  • 2马秀兰,宋淑云,叶建新,李秋娟.对成年大鼠脏器系数的探讨[J].动物学杂志,1996,31(3):25-26. 被引量:31
  • 3钟石,计东风,陈诗,胡桂燕,李有贵.蛹虫草研究进展[J].蚕桑通报,2007,38(1):6-10. 被引量:32
  • 4Wu KM, Hunter TL, Proakis AGI. A dual electrophysiologic test for atrial antire-entruy and ventricular antifibrillatory studies[J]. J Pharmacol Meth. 1990 ; 23 (2) :87.
  • 5Wu KM, ProakisAG, Hunter TL, etal. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models of arrhythmial[J]. Arch Int Pharmacodyn. 1989,301 (2) : 131.
  • 6Jiro Arita, Yi xue xue, Nu Nu Aye, et al. Antiarrhythmic effects of an aconitine-like compound, TJN-505,on canine arrhythmia models[J]. Eur J Pharmacol, 1996,318(2):333.
  • 7Nakayama K, OshimaT, Kumakura S, etal. Comparison of the effects various β-adrenergic blocking agents with known antiarrhythmic drugs on aconitinearrhythmia produced by the method[J]. Eur J Pharmacol,1971,14(1) ,9.
  • 8Yamamoto T, Hosoki K, Karasawa T. Anti-atrhythmic effects of a new calcium antagonist, Monopetil,AJ-2615, in experimental arrhythmic models[J]. Clin Exper Pharmacol Physiol, 1993,20(2) :497.
  • 9Kazuya I, Daisuke I, Ryuta S, et al. Effects of disopyramide on the atrial fibrillation threshold in the human atrium[J]. Int J Cardiology,1995,52(2);177.
  • 10Flavia Ravelli. Mechano-electric feedback and atrial fibrillation[J]. Prog Biophys Mol Biol, 2003,82(2):137.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部